Patients who underwent Xen gel stent implantation combined with phacoemulsification to treat primary or secondary open-angle glaucoma experienced a similar central endothelial cell density loss at 2 years as those who underwent stand-alone phacoemulsification, according to a study.
“After 2 years, Xen gel stent does not seem to cause an additional ECD loss than cataract surgery alone,” study co-author Kaweh Mansouri, MD, told Healio/OSN.
The retrospective study included 32 eyes of 23 patients. Fifteen eyes underwent stand-alone phaco, and 17 eyes underwent phaco combined with Xen
Uncategorized